Peptide library
All 46 research peptides
Fifteen peptides covering cognitive enhancement, neuroprotection, anxiolytic effects, sleep modulation, and neurogenesis. All entries are for laboratory research reference only.
Browse by category
Browse by mechanism
Cognitive Enhancement
View all 12 →Semax
A synthetic heptapeptide analogue of ACTH(4-10) developed in Russia for cognitive enhancement, neuroprotection, and stroke recovery research.
Read profileNoopept (Peptide Note)
A small proline-containing dipeptide derivative — technically a peptidomimetic — developed in Russia as an orally active cognitive enhancer with structural lineage to piracetam.
Read profileN-Acetyl Semax Amidate
A chemically protected analogue of Semax with N-terminal acetylation and C-terminal amidation, conferring substantially extended half-life and improved potency in research.
Read profileCycloprolylglycine
An endogenous cyclic dipeptide that is also the primary active metabolite of Noopept, with intrinsic anxiolytic and cognitive effects independent of its parent compound — a research peptide in its own right.
Read profileTesamorelin
A licensed GHRH(1-44) analogue with a positive cognitive-effect trial in HIV-associated neurocognitive disorder — the strongest cognitive-endpoint evidence in the GH-axis peptide family.
Read profileDDAVP (Desmopressin)
A licensed synthetic vasopressin analogue with documented memory-modulation effects — one of the classical vasopressin-family cognitive research peptides with the deepest historical literature.
Read profileDGAVP
A classical De Wied-laboratory vasopressin analogue engineered to preserve memory-relevant central effects while eliminating the pressor effect of parent vasopressin — the reference vasopressin-family cognitive research peptide of the 1970s-80s.
Read profileOrg 2766
A classical Dutch/Organon ACTH(4-9) analogue closely related to Semax — the direct pharmacological cousin of the Russian cognitive-peptide programme's flagship compound, with independent memory and neuroprotective research history.
Read profileACTH(4-10)
The parent 4-10 fragment of adrenocorticotropic hormone from which Semax derives — the classical ACTH-fragment cognitive-research peptide with foundational historical significance in the vasopressin/ACTH memory-peptide programme.
Read profileMIF-1
A tripeptide originally identified as an inhibitor of melanocyte-stimulating hormone release, with a distinctive research history spanning memory modulation, dopamine-receptor allosteric effects, and Parkinson's-disease-adjacent research applications.
Read profileTRH (Thyrotropin-releasing hormone)
The endogenous hypothalamic tripeptide that stimulates thyroid-stimulating hormone release, with distinctive research history in cognitive effects, arousal, mood modulation, and neuroprotective applications separated from the primary thyroid-axis pharmacology.
Read profileVasopressin
The endogenous nonapeptide antidiuretic hormone with distinctive central memory-modulation effects — the parent compound of the classical vasopressin-family cognitive research programme and the direct hormone from which DDAVP and DGAVP were engineered.
Read profileNeuroprotection
View all 18 →Pinealon
A short tripeptide bioregulator studied in Russian gerontology research for neuroprotective and anti-ageing effects on the central nervous system.
Read profileCerebrolysin
A complex mixture of low-molecular-weight peptides and free amino acids derived from porcine brain tissue, studied extensively in cognitive decline and post-stroke recovery research.
Read profileEpitalon
A short synthetic tetrapeptide developed in the Khavinson bioregulator programme, studied for telomere maintenance, pineal regulation, and indirect cognitive effects via circadian and stress-resilience pathways.
Read profileCortexin
A standardised low-molecular-weight peptide preparation derived from bovine cerebral cortex, used in Russian clinical practice for cognitive impairment, post-stroke recovery, and traumatic brain injury research — the closest single sister to Cerebrolysin.
Read profileBPC-157
A synthetic 15-amino-acid peptide derived from a fragment of human gastric juice protein, studied for tissue-repair, gut-brain-axis, and emerging neuroprotective and cognitive-relevant effects.
Read profileSemaglutide
A long-acting GLP-1 receptor agonist licensed for type-2 diabetes and obesity, with an active Phase III cognitive-endpoint trial in Alzheimer's disease (EVOKE) — the highest-profile emerging cognitive-relevance peptide of the 2020s.
Read profileSS-31 (Elamipretide)
A mitochondrially-targeted tetrapeptide that binds cardiolipin on the inner mitochondrial membrane, studied for mitochondrial-dysfunction diseases and emerging cognitive-ageing research applications.
Read profileCortagen
A synthetic tetrapeptide from the Khavinson bioregulator programme (Ala-Glu-Asp-Pro), positioned as a brain-cortex-targeted bioregulator complementing Pinealon and Cortexin.
Read profileTB-500 (Thymosin Beta-4 fragment)
A synthetic fragment of the endogenous 43-amino-acid thymosin β4 protein, studied for tissue-repair, angiogenesis, and emerging CNS regeneration and neuroprotection applications.
Read profileHumanin
A 21-24-amino-acid mitochondrial-derived peptide with cytoprotective and neuroprotective activity — the flagship member of the mitochondrial-derived peptide family, with emerging evidence in Alzheimer's disease and cognitive-ageing research.
Read profileVesugen
A Khavinson vascular short peptide (Lys-Glu-Asp) targeting vascular-endothelial gene expression, with cerebrovascular research relevance in cognitive-ageing and stroke-recovery contexts.
Read profileEndoluten
A Khavinson pineal peptide preparation covering the pineal-gland-directed bioregulator angle alongside Epitalon — used in Russian gerontology practice for circadian and gerontoprotective effects.
Read profileN-Acetyl Epitalon Amidate
A chemically protected analogue of Epitalon with N-terminal acetylation and C-terminal amidation — same pineal-directed pharmacology as parent Epitalon with extended half-life, mirroring the NA-Semax and NA-Selank pattern.
Read profileLiraglutide
The predecessor long-acting GLP-1 receptor agonist to semaglutide, with the completed ELAD Phase II trial in Alzheimer's disease — the reference cognitive-endpoint trial for the GLP-1 class before EVOKE.
Read profileCellex
A Russian/Belarusian porcine-brain-derived sialic-acid peptide preparation used clinically for neurological indications, similar in architecture to Cerebrolysin but with a distinct compositional and clinical positioning.
Read profileKPV
The α-MSH 11-13 tripeptide fragment (Lys-Pro-Val) with anti-inflammatory activity mediated through melanocortin-receptor-adjacent mechanisms — studied for gut, skin, and emerging neuroinflammation research applications.
Read profileThymulin
A zinc-bound nonapeptide thymic hormone with distinctive research applications spanning immune-cognitive research, sickness-behaviour research, and neuroinflammation-mediated cognitive-decline contexts.
Read profileCarnosine
An endogenous dipeptide (β-alanyl-L-histidine) with distinctive antioxidant, anti-glycation, and metal-chelating properties supporting cellular-protection research applications spanning neuroprotection, cognitive-ageing, and metabolic-cognitive contexts.
Read profileAnxiolytic / Mood
View all 3 →Selank
A synthetic heptapeptide analogue of tuftsin developed for anxiolytic and immunomodulatory research, with measurable effects on attention and mood.
Read profileN-Acetyl Selank Amidate
Chemically protected analogue of Selank with extended half-life through N-terminal acetylation and C-terminal amidation; same anxiolytic profile as the parent compound with longer duration.
Read profileOxytocin (intranasal)
The endogenous nonapeptide 'social bonding' hormone, studied via intranasal delivery for social cognition, anxiety, and trust-related research endpoints — one of the most-researched peptides in cognitive neuroscience.
Read profileSleep & Recovery
View all 6 →DSIP
A nonapeptide originally isolated from the cerebral venous blood of sleeping rabbits, studied for sleep modulation, stress resilience, and indirect cognitive effects.
Read profileCJC-1295
A modified GHRH(1-29) analogue commonly stacked with GH-releasing peptides for GH-axis research, with an indirect cognitive-relevance angle via sleep-architecture support and IGF-1 signalling.
Read profileIpamorelin
A selective ghrelin-receptor agonist growth-hormone-releasing peptide, most commonly stacked with CJC-1295 for physiological GH-pulse research — the reference selective GHRP in modern research practice.
Read profileSermorelin
The 1-29 amino acid fragment of endogenous growth hormone-releasing hormone (GHRH), historically licensed for paediatric growth hormone deficiency diagnostics and long the reference GHRH research analogue prior to CJC-1295's dominance.
Read profileHexarelin
A synthetic hexapeptide growth-hormone-releasing peptide with the most potent GH-releasing activity in the class, and distinctive cardioprotective effects mediated by a non-GH-mediated mechanism.
Read profileGHRP-2
The reference growth-hormone-releasing peptide developed as a diagnostic and research tool for GH-axis characterisation, with well-established GH-releasing pharmacology and licensed diagnostic use in some jurisdictions.
Read profileNeurogenesis
View all 7 →Dihexa
An orally active hexapeptide derivative of angiotensin IV, characterised in academic research as among the most potent known pro-cognitive compounds in animal models.
Read profileFGL Peptide
A 15-amino-acid peptide mimetic of the FGL loop of the neural cell adhesion molecule (NCAM), studied for neurogenic, synaptogenic, and memory-enhancing effects in cellular and animal research.
Read profileP21
A small peptide derived from a neurotrophic-cytokine framework, characterised in academic research for hippocampal neurogenesis induction and anti-neuroinflammatory effects in models of cognitive ageing and Alzheimer-type pathology.
Read profileGHK-Cu (cognitive angle)
A naturally occurring tripeptide-copper complex best known for skin and tissue-repair effects, but with a distinct cognitive-research literature covering gene-expression modulation, antioxidant defence, and indirect neurotrophic effects.
Read profileDavunetide
An 8-amino-acid ADNP-derived peptide (NAPVSIPQ) evaluated in multiple neurodegenerative disease trials — the flagship clinical-trial peptide in the synaptogenic / neuroprotective family.
Read profileARA-290 (Cibinetide)
An 11-amino-acid non-erythropoietic EPO analogue, studied for tissue-protective and neuroprotective effects mediated by the innate repair receptor (IRR) — a distinctive mechanism separated from EPO's erythropoietic activity.
Read profileIGF-1 LR3
A synthetic long-acting analogue of insulin-like growth factor 1 with reduced IGF-binding-protein affinity, providing sustained systemic IGF-1 signalling with direct hippocampal-neurogenesis implications.
Read profile